December 31, 2024 The company is exploring the potential for continued development of its norovirus vaccine candidates in adults ...

BOSTON, March 28, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial ...

Kyverna reported $286.0M in cash, cash equivalents, and available-for-sale marketable securities as of December 31, 2024. The company expects ...

Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision ...

"Zentalis reported significant progress in the development of azenosertib in 2024 and made important advancements this year. We plan to maintain strong execution on the late-stage development of ...

Meta Platforms' net cash and marketable securities position reached a record high to close out 2024. Read why I remain ...

Herc will finance the offer through a combination of available cash on hand, proceeds from the sale of marketable securities ...

One beaten-down Magnificent Seven stock that's looking increasingly appealing is Alphabet. It's down about 20% from February's all-time high, but its business has a ton of momentum behind it. If ...

Michael Jordan named the basketball player that was just as good as him but wasn't as marketable in a revealing admission. Jordan enjoyed a stunning career in the NBA with the Chicago Bulls ...